8.910EUR+1.25%Mkt Cap: 120.82M $P/E: —1d ago
Guerbet SA provides a range of contrast media, medical devices, and digital and AI solutions for diagnostic and interventional imaging worldwide. It offers DOTAREM, a macrocyclic gadolinium-based contrast agent for use i…
Industry Peers
Medical DevicesIndicators:|
Key Statistics
Company
Market Cap120.82M $
Enterprise Value467.99M $
Revenue (TTM)868.12M $
Gross Profit615.42M $
Net Income (TTM)-117.75M $
Revenue/Share68.82 USD
Last Price8.910 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees2.7K
CountryFR
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)3.62
PEG0.07
EV/EBITDA9.37
EV/Revenue0.54
P/S0.14
P/B0.42
EPS (TTM)-8.91
EPS (Forward)2.44
52W Range
8.0106% of range23.40
52W High23.40 EUR
52W Low8.010 EUR
Profitability
Gross Margin70.89%
Oper. Margin-1.70%
EBITDA Margin5.76%
Profit Margin-13.56%
ROE-40.57%
ROA-11.65%
Growth
Revenue Growth-5.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF88.14M $
CapEx (TTM)39.79M $
FCF Margin9.29%
FCF Yield66.77%
Net Debt354.02M $
Net Debt/EBITDA7.08
Balance Sheet
Debt/Equity1.65
Current Ratio2.49
Quick Ratio1.08
Book Value/Sh21.16 EUR
Cash/Share9.158 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split4:1
Split DateJan 23, 2014
Analyst Consensus
Rating3.7 (Underperform)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)11.60 EUR
Upside (mean)+30.2%
Target Range9.000 EUR – 13.80 EUR
€9.000+30.2% to mean€13.80
# Analysts3
Ownership
Shares Out.12.55M
Float5.26M
Insiders63.21%
Institutions6.58%
Technical
SMA 509.679 (-7.9%)
SMA 20012.36 (-27.9%)
Beta1.00
S&P 52W Chg20.25%
Avg Vol (30d)11.88K
Avg Vol (10d)9.73K
Technical Indicators
RSI (14)41.8
MACD-0.2562
MACD Signal-0.2971
MACD Hist.+0.0409
BB Upper9.365 EUR
BB Middle8.975 EUR
BB Lower8.584 EUR
BB Width8.70%
ATR (14)0.2516 EUR
Vol Ratio (20d)0.54x